Fertility and Sterility
Volume 93, Issue 5 , Pages 1440-1447 , 15 March 2010

15-Epi-lipoxin A4 inhibits the progression of endometriosis in a murine model

  • Qiong-Hua Chen, Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Tongji Hospital of Tongji Medical college of Huazhong University of Science & Technology, Wuhan, People's Republic of China
    • Department of Obstetrics and Gynecology, Xiamen First Hospital affiliated by Fujian Medical University, Xiamen, People's Republic of China
    • ,
  • Wei-Dong Zhou, Ph.D.

      Affiliations

    • Key Laboratory of Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen, People's Republic of China
    • ,
  • De-Min Pu, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Tongji Hospital of Tongji Medical college of Huazhong University of Science & Technology, Wuhan, People's Republic of China
    • Corresponding Author InformationReprint requests: De-Min Pu, M.D., Department of Obstetrics and Gynecology, Tongji Hospital of Tongji Medical college of Huazhong University of Science & Technology, Wuhan 430030, P.R. China (FAX: +86-027-83629052).
    • ,
  • Qian-Sheng Huang, Ph.D.

      Affiliations

    • Key Laboratory of Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen, People's Republic of China
    • ,
  • Tian Li, Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Tongji Hospital of Tongji Medical college of Huazhong University of Science & Technology, Wuhan, People's Republic of China
    • ,
  • Qing-Xi Chen, Ph.D.

      Affiliations

    • Key Laboratory of Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen, People's Republic of China

Received 7 November 2008 ,Revised 13 January 2009 ,Accepted 15 January 2009.

References 

  1. Kyama CM, Overbergh L, Mihalyi A, Meuleman C, Mwenda JM, Mathieu C, et al. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril. 2008;89:301–310
  2. Dogan E, Saygili U, Posacı C. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertil Steril. 2004;82:1115–1120
  3. Li YG, Pu DM, Li YL. The expression of cyclooxygenase-2 in cervical cancers and Hela cells was regulated by estrogen/progestogen. J Huazhong Univ Sci Technol. 2007;27:457–460
  4. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999;5:698–701
  5. Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case–control study. Lancet. 2005;365:475–481
  6. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352:1092–1102
  7. Gilroy DW, Lawrence T, Perretti M, Rossi AG. Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov. 2004;3:401–416
  8. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6:1191–1197
  9. Serhan CN. Endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 2007;25:101–137
  10. Motohashi E, Kawauchi H, Endo H, Kondo H, Kitasato H, Kuramoto H, et al. Regulatory expression of lipoxinA4 receptor in physiologically estruscycle and pathologically endometriosis. Biomed Pharmacother. 2005;59:330–338
  11. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990;6:121–125
  12. Chen QH, Qu JY, Xu YY, Qiu NX, Zhuang YZ, Zhong S, et al. Expressions of matrix metalloproteinase-9 and tissue inhibitorof metalloproteinase-1 in ectopic and eutopic endometrium. Chin J Obstet Gynecol. 2004;39:809–812
  13. Li T, Li YG, Pu DM. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest. 2006;62:229–235
  14. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 2004;16:558–564
  15. Luttikhuizen DT, Van Amerongen MJ, De Feijter PC, Petersen AH, Harmsen MC, Van Luyn MJ. The correlation between difference in foreign body reaction between implant locations and cytokine and MMP expression. Biomaterials. 2006;27:5763–5770
  16. Dabrosin C, Gyorffy S, Margetts P, Ross C, Gauldie J. Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. Am J Pathol. 2002;161:909–918
  17. Cao ZY. Chinese obstetrics and gynecology. In:  Gao Y editors. The pathology of endometriosis. Vol. 2:Beijing: People's Health Publishing House; 2004;p. 1486–1488
  18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–408
  19. Rugh R. The mouse: its reproduction and development. New York: Oxford University; 1990;
  20. Becker CM, Sampson DA, Rupnick MA, Rohan RM, Efstathiou JA, Short SM, et al. Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. Fertil Steril. 2005;84:1144–1155
  21. Hughes E, Brown J, Collins JJ, Farquhar C, Fedorkow DM, Vandekerckhove P. Ovulation suppression for endometriosis. Cochrane Database Syst Rev. 2007;18:CD000155
  22. Olivares C, Bilotas M, Buquet R, Borghi M, Sueldo C, Tesone M, et al. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Hum Reprod. 2008;23:2701–2708
  23. Majno G. The healing hand: man and wound in the ancient world. Cambridge, MA: Harvard University Press; 1991;
  24. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2:612–619
  25. Haworth O, Buckley DC. Resolving the problem of persistence in the switch from acute to chronic inflammation. Proc Natl Acad Sci USA. 2007;104:20647–20684
  26. Schwab JM, Nan C, Makoto A, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007;447:869–874
  27. Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol. 2008;3:279–312
  28. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349–361
  29. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol. 2001;69:851–859
  30. Mulayim N, Savlu A, Guzeloglu-Kayisli O, Kayisli UA, Arici A. Regulation of endometrial stromal cell matrix metalloproteinase activity and invasiveness by interleukin-8. Fertil Steril. 2004;81:904–911
  31. Sodin-Semrl S, Taddeo B, Tseng D, Varga J, Fiore S. Lipoxin A4 inhibits IL-1β-induced IL-6, IL-8 and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol. 2000;164:2660–2666
  32. Deura I, Harada T, Taniguchi F, Iwabe T, Izawa M, Terakawa N. Reduction of estrogen production by interleukin-6 in a human granulosa tumor cell line may have implications for endometriosis-associated infertility. Fertil Steril. 2005;83:1086–1092
  33. Di Carlo C, Bonifacio M, Tommaselli GA, Bifulco G, Guerra G, Nappi C. Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium. Fertil Steril (in press).
  34. Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Vila V, Réganon E, et al. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod. 2007;22:2120–2127

 Q.-H.C. has nothing to disclose. W.-D.Z. has nothing to disclose. D.-M.P. has nothing to disclose.Q.-S.H. has nothing to disclose. T.L. has nothing to disclose. Q.-X.C. has nothing to disclose.

 Supported by grant 2007-1-43 of the Ministry of Health of Fujian Province, P.R. China, by grant 2009-CXB-49 of the medical innovation project of Fujian Province, P.R. China, by grant 3502 Z 20077047 of the Science & Technology Planning Project of Xiamen City, P.R. China, and by grant 3502 Z 20084006 of the Science & Technology Planning Project of Xiamen City, P R. China.

PII: S0015-0282(09)00143-5

doi: 10.1016/j.fertnstert.2009.01.107

Fertility and Sterility
Volume 93, Issue 5 , Pages 1440-1447 , 15 March 2010

Article Tools

* Image Usage & Resolution